No Prescription |
 |
 | ||
|
Calvasc Norvasc |
|
| ||
No Prescription » Prescription Drugs 3 » Calvasc Norvasc Calvasc is used to treat high blood pressure (hypertension). High blood pressure usually has no symptoms. Having your blood pressure checked on a regular basis is the only way of knowing that you have hypertension. Untreated high blood pressure can lead to serious health problems.Calvasc belongs to a group of medicines called calcium channel blockers or calcium ion antagonists. These medicines work by widening your blood vessels. This makes it easier for your heart to pump blood around the body while also increasing the supply of blood and oxygen to your heart. Calcium channel blockers do not change the amount of calcium in your blood or bones.Calvasc is also used to treat angina pectoris. This pain is due to your heart not receiving enough oxygen. It is felt as a pain or uncomfortable feeling in the chest often spreading to the arms or neck and sometimes to the shoulders and back. Calvasc cannot be used for the relief of a sudden attack of angina. Your doctor will have given you other medication to treat sudden attacks. Buy Calvasc Norvasc and other Prescription Drugs 3 products online at Medstore. Buy Online at Medstore - Click Here!
About Calvasc Norvasc: Product Type: Prescription Drugs 3 Calvasc ( Norvasc Generic Amlodipine ) Calvasc (Norvasc Generic Amlodipine) Norvasc Generic Amlodipine 10mg 30 Tablets 90(3 x 30) Tablets 5mg 90(3 x 30) Tablets 30 Tablets Norvasc Generic Amlodipine Calvasc
View more Prescription Drugs 3 No Prescription: NEW YORK, Oct. 5, 2011 /PRNewswire via COMTEX/ -- Reportlinker.com announces that a new market research report is available in its catalogue: European Pharmaceutical Market: Strategic Assessments of Leading Suppliers http://www.reportlinker.com/p0651431/European-Pharmaceutical-Market-Strategic-Assessments-of-Leading-Suppliers.html #utm_source=prnewswire&utm_medium=pr&utm_campaign=Drug_and_Medication This report provides industry executives with strategically significant competitor information and analysis of the leading players in the European pharmaceutical market. The report provides a worldwide strategic overview of the pharmaceutical market, including: Sales forecast for major product segments: ethical, OTC, generics. Sales forecast for major drug categories: cardiovascular, gastrointestinal, antibiotic, CNS, respiratory, musculoskeletal, hormonal/genitourinary, dermatological, oncological, ophthalmic, and others. In addition, the report reviews major regulatory, technological, economic, demographic, and social trends with potentially significant impact on the market during the next five years, including discussion of such key issues as pricing, industry consolidation, market globalization, growing R&D cost, generics, as well as advances in genomics, proteomics, drug screening, tissue engineering, bioinformatics, and other technologies. The companies analyzed in this report include Abbott, AstraZeneca, Bristol-Myers Squibb, Eli Lilly, GlaxoSmithKline, Johnson & Johnson, Merck, Novartis, Pfizer, Roche, Sanofi-Aventis and Wyeth.
| ||
